NCT02307656 | Study Connect

Ask a Question

Ask your question and our customer service team will answer it as soon as they can. Questions that do not contain personal information may be posted to our help center to be of service to others.

* Required field

Your Email Address *

Please enter valid email address.

Choose a Topic *

Tell us your question and any additional information *

Please enter all required fields.

Please Log In/Join Now first, and then use this function!

Not Yet Recruiting

Taste Properties of Atazanavir and Cobicistat - AI424-517

Updated: 15 February, 2018 | ClinicalTrials.gov

About This Trial
Key Eligibility Criteria
Trial Site Locations

Print Friendly Summary

CONSIDERING THIS TRIAL?

Print this page and the trial guide to help you talk with your doctor.

Use the Study Participant's Guide to navigate the process of participating in a clinical trial. Understand key factors to consider before deciding and get questions to ask your healthcare team.

Print this page AI424-517

Download Study Participant’s Guide

SELECT LANGUAGE

Trial Details

Phase 1

Phase
Gender(s)
18+

Age Range
Not Yet Recruiting

Treatment Options

Study Arms

ASSIGNED INTERVENTION

Other: Atazanavir and Cobicistat

Drug: Active Pharmaceutical Ingredient Drug: Cobicistat Drug: Atazanavir

Key Eligibility Criteria

For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com Inclusion Criteria: - Men and women, ages ≥18 years - Subjects who are qualified professional sensory panelists - Healthy subjects as determined by no clinically significant deviation from normal in medical history and physical assessment Exclusion Criteria: - Any acute or chronic condition that may alter taste or smell sensory perception - Any significant acute or chronic medical illness or any surgery within 4 weeks of the study drug administration - Positive HIV test using an oral swab kit (such as OraQuick®) to detect HIV-1 or -2 antibody

Have questions? Email Us

Have questions?

Email Us